- Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
-
Tiede A, Stockhoff L, Liu Z, Rieland H, Mauz JB, Ohlendorf V, Bremer B, Witt J, Kraft A, Cornberg M, Hinrichs JB, Meyer BC, Wedemeyer H, Xu CJ, Falk CS, Maasoumy B
- KMID: 2563423
- Clin Mol Hepatol.
- 2025 Jan;31(1):240-255.
- doi: 10.3350/cmh.2024.0587
Background/Aims: Systemic Inflammation (SI) is considered a key mechanism in disease progression and development of complications in decompensated liver cirrhosis. SI is mainly driven by portal hypertension and bacterial translocation.... -
- CITED
-
- Close
- SHARE
-
- Close
